从2016年成立到IPO，Structure累计筹集了1.98亿美元。2021年，该公司完成了1亿美元的B轮融资，去年8月又增补了3300万美元。文件显示，该生物技术公司的最大股东是红杉资本中国基金，它拥有7.65%的上市后股份。BVF Partners拥有7.1%的股份；ERVC Healthcare拥有6.2%。

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best performers on Monday. Structure Therapeutics soared to ...

Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 14 best booming stocks to buy right now. The company’s shares have gained over 130% in the past three months, with a major surge since early ...

Capsule-to-tablet study demonstrated a placebo-adjusted mean weight loss of upto 6.9% with the tablet formulation. The company plans to initiate a Phase 2b obesity study of GSBR-1290 in the fourth ...

Fintel reports that on May 2, 2025, Citigroup initiated coverage of Structure Therapeutics Inc. - Depositary Receipt () (NasdaqGM:GPCR) with a Buy recommendation. As of April 24, 2025, the average one ...

Structure Therapeutics has a promising GLP-1 drug that is about to enter phase 3 trials.

Fintel reports that on February 28, 2025, William Blair initiated coverage of Structure Therapeutics Inc. - Depositary Receipt () (NasdaqGM:GPCR) with a Outperform recommendation. As of February 19, ...

We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts. In this article, we are going to take a look at where Structure Therapeutics Inc. (NASDAQ:GPCR) stands ...